Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | yes | yes: 35 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 7 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 21 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 15 |
NetGPI | no | yes: 0, no: 15 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005840 | ribosome | 5 | 14 |
GO:0032991 | protein-containing complex | 1 | 16 |
GO:0043226 | organelle | 2 | 14 |
GO:0043228 | non-membrane-bounded organelle | 3 | 14 |
GO:0043229 | intracellular organelle | 3 | 14 |
GO:0043232 | intracellular non-membrane-bounded organelle | 4 | 14 |
GO:0110165 | cellular anatomical entity | 1 | 14 |
GO:1990904 | ribonucleoprotein complex | 2 | 16 |
GO:0015935 | small ribosomal subunit | 4 | 2 |
GO:0022627 | cytosolic small ribosomal subunit | 5 | 2 |
GO:0044391 | ribosomal subunit | 3 | 2 |
Related structures:
AlphaFold database: A4H3R3
Term | Name | Level | Count |
---|---|---|---|
GO:0006412 | translation | 4 | 16 |
GO:0006518 | peptide metabolic process | 4 | 16 |
GO:0006807 | nitrogen compound metabolic process | 2 | 16 |
GO:0008152 | metabolic process | 1 | 16 |
GO:0009058 | biosynthetic process | 2 | 16 |
GO:0009059 | macromolecule biosynthetic process | 4 | 16 |
GO:0009987 | cellular process | 1 | 16 |
GO:0019538 | protein metabolic process | 3 | 16 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 16 |
GO:0034645 | obsolete cellular macromolecule biosynthetic process | 4 | 16 |
GO:0043043 | peptide biosynthetic process | 5 | 16 |
GO:0043170 | macromolecule metabolic process | 3 | 16 |
GO:0043603 | amide metabolic process | 3 | 16 |
GO:0043604 | amide biosynthetic process | 4 | 16 |
GO:0044237 | cellular metabolic process | 2 | 16 |
GO:0044238 | primary metabolic process | 2 | 16 |
GO:0044249 | cellular biosynthetic process | 3 | 16 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 16 |
GO:0044271 | cellular nitrogen compound biosynthetic process | 4 | 16 |
GO:0071704 | organic substance metabolic process | 2 | 16 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 16 |
GO:1901566 | organonitrogen compound biosynthetic process | 4 | 16 |
GO:1901576 | organic substance biosynthetic process | 3 | 16 |
GO:0000028 | ribosomal small subunit assembly | 7 | 2 |
GO:0016043 | cellular component organization | 3 | 2 |
GO:0022607 | cellular component assembly | 4 | 2 |
GO:0022618 | ribonucleoprotein complex assembly | 6 | 2 |
GO:0043933 | protein-containing complex organization | 4 | 2 |
GO:0065003 | protein-containing complex assembly | 5 | 2 |
GO:0071826 | ribonucleoprotein complex subunit organization | 5 | 2 |
GO:0071840 | cellular component organization or biogenesis | 2 | 2 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003735 | structural constituent of ribosome | 2 | 16 |
GO:0005198 | structural molecule activity | 1 | 16 |
GO:0003676 | nucleic acid binding | 3 | 2 |
GO:0003723 | RNA binding | 4 | 2 |
GO:0005488 | binding | 1 | 2 |
GO:0097159 | organic cyclic compound binding | 2 | 2 |
GO:1901363 | heterocyclic compound binding | 2 | 2 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_MEL_PAP_1 | 156 | 162 | PF00089 | 0.402 |
CLV_NRD_NRD_1 | 205 | 207 | PF00675 | 0.414 |
CLV_NRD_NRD_1 | 221 | 223 | PF00675 | 0.456 |
CLV_NRD_NRD_1 | 38 | 40 | PF00675 | 0.522 |
CLV_NRD_NRD_1 | 77 | 79 | PF00675 | 0.565 |
CLV_NRD_NRD_1 | 81 | 83 | PF00675 | 0.576 |
CLV_PCSK_KEX2_1 | 158 | 160 | PF00082 | 0.402 |
CLV_PCSK_KEX2_1 | 38 | 40 | PF00082 | 0.522 |
CLV_PCSK_KEX2_1 | 58 | 60 | PF00082 | 0.573 |
CLV_PCSK_KEX2_1 | 77 | 79 | PF00082 | 0.561 |
CLV_PCSK_KEX2_1 | 81 | 83 | PF00082 | 0.581 |
CLV_PCSK_PC1ET2_1 | 158 | 160 | PF00082 | 0.402 |
CLV_PCSK_PC1ET2_1 | 58 | 60 | PF00082 | 0.481 |
CLV_PCSK_PC1ET2_1 | 81 | 83 | PF00082 | 0.649 |
CLV_PCSK_PC7_1 | 34 | 40 | PF00082 | 0.515 |
CLV_PCSK_PC7_1 | 77 | 83 | PF00082 | 0.623 |
CLV_PCSK_SKI1_1 | 101 | 105 | PF00082 | 0.402 |
CLV_PCSK_SKI1_1 | 186 | 190 | PF00082 | 0.453 |
CLV_PCSK_SKI1_1 | 83 | 87 | PF00082 | 0.500 |
CLV_PCSK_SKI1_1 | 94 | 98 | PF00082 | 0.465 |
DEG_APCC_DBOX_1 | 45 | 53 | PF00400 | 0.576 |
DEG_SPOP_SBC_1 | 174 | 178 | PF00917 | 0.546 |
DOC_CKS1_1 | 27 | 32 | PF01111 | 0.506 |
DOC_CYCLIN_yCln2_LP_2 | 8 | 14 | PF00134 | 0.469 |
DOC_MAPK_gen_1 | 101 | 111 | PF00069 | 0.449 |
DOC_MAPK_gen_1 | 206 | 217 | PF00069 | 0.395 |
DOC_USP7_MATH_1 | 184 | 188 | PF00917 | 0.435 |
DOC_USP7_UBL2_3 | 104 | 108 | PF12436 | 0.454 |
DOC_USP7_UBL2_3 | 186 | 190 | PF12436 | 0.397 |
DOC_WW_Pin1_4 | 26 | 31 | PF00397 | 0.506 |
DOC_WW_Pin1_4 | 44 | 49 | PF00397 | 0.491 |
DOC_WW_Pin1_4 | 51 | 56 | PF00397 | 0.464 |
LIG_14-3-3_CanoR_1 | 3 | 9 | PF00244 | 0.554 |
LIG_14-3-3_CanoR_1 | 59 | 67 | PF00244 | 0.739 |
LIG_14-3-3_CanoR_1 | 82 | 88 | PF00244 | 0.586 |
LIG_14-3-3_CanoR_1 | 94 | 103 | PF00244 | 0.216 |
LIG_Actin_WH2_2 | 72 | 90 | PF00022 | 0.618 |
LIG_BRCT_BRCA1_1 | 156 | 160 | PF00533 | 0.402 |
LIG_BRCT_BRCA1_1 | 213 | 217 | PF00533 | 0.474 |
LIG_BRCT_BRCA1_1 | 24 | 28 | PF00533 | 0.509 |
LIG_FHA_1 | 113 | 119 | PF00498 | 0.361 |
LIG_FHA_1 | 176 | 182 | PF00498 | 0.546 |
LIG_FHA_1 | 27 | 33 | PF00498 | 0.506 |
LIG_FHA_2 | 84 | 90 | PF00498 | 0.396 |
LIG_LIR_Nem_3 | 132 | 136 | PF02991 | 0.402 |
LIG_LIR_Nem_3 | 91 | 96 | PF02991 | 0.499 |
LIG_LRP6_Inhibitor_1 | 71 | 77 | PF00058 | 0.525 |
LIG_LYPXL_yS_3 | 66 | 69 | PF13949 | 0.455 |
LIG_PDZ_Class_1 | 224 | 229 | PF00595 | 0.562 |
LIG_SH2_CRK | 153 | 157 | PF00017 | 0.422 |
LIG_SH2_STAT3 | 13 | 16 | PF00017 | 0.472 |
LIG_SH2_STAT5 | 13 | 16 | PF00017 | 0.472 |
LIG_SH2_STAT5 | 135 | 138 | PF00017 | 0.402 |
LIG_SH2_STAT5 | 146 | 149 | PF00017 | 0.402 |
LIG_SH3_3 | 125 | 131 | PF00018 | 0.420 |
LIG_TRFH_1 | 13 | 17 | PF08558 | 0.467 |
LIG_TYR_ITIM | 151 | 156 | PF00017 | 0.445 |
MOD_CDK_SPxxK_3 | 51 | 58 | PF00069 | 0.477 |
MOD_CK1_1 | 23 | 29 | PF00069 | 0.647 |
MOD_CK1_1 | 4 | 10 | PF00069 | 0.463 |
MOD_CK1_1 | 44 | 50 | PF00069 | 0.489 |
MOD_CK1_1 | 54 | 60 | PF00069 | 0.454 |
MOD_CK1_1 | 65 | 71 | PF00069 | 0.555 |
MOD_CK2_1 | 165 | 171 | PF00069 | 0.402 |
MOD_Cter_Amidation | 79 | 82 | PF01082 | 0.565 |
MOD_GlcNHglycan | 199 | 202 | PF01048 | 0.413 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.631 |
MOD_GlcNHglycan | 43 | 46 | PF01048 | 0.619 |
MOD_GlcNHglycan | 89 | 93 | PF01048 | 0.513 |
MOD_GSK3_1 | 170 | 177 | PF00069 | 0.513 |
MOD_GSK3_1 | 22 | 29 | PF00069 | 0.505 |
MOD_GSK3_1 | 44 | 51 | PF00069 | 0.591 |
MOD_N-GLC_1 | 112 | 117 | PF02516 | 0.474 |
MOD_N-GLC_1 | 174 | 179 | PF02516 | 0.298 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.579 |
MOD_NEK2_1 | 117 | 122 | PF00069 | 0.533 |
MOD_NEK2_1 | 211 | 216 | PF00069 | 0.546 |
MOD_NEK2_1 | 224 | 229 | PF00069 | 0.523 |
MOD_PKA_2 | 202 | 208 | PF00069 | 0.421 |
MOD_Plk_1 | 170 | 176 | PF00069 | 0.563 |
MOD_Plk_1 | 20 | 26 | PF00069 | 0.494 |
MOD_Plk_1 | 88 | 94 | PF00069 | 0.487 |
MOD_Plk_4 | 23 | 29 | PF00069 | 0.748 |
MOD_Plk_4 | 4 | 10 | PF00069 | 0.632 |
MOD_Plk_4 | 48 | 54 | PF00069 | 0.660 |
MOD_ProDKin_1 | 26 | 32 | PF00069 | 0.506 |
MOD_ProDKin_1 | 44 | 50 | PF00069 | 0.489 |
MOD_ProDKin_1 | 51 | 57 | PF00069 | 0.465 |
MOD_SUMO_for_1 | 103 | 106 | PF00179 | 0.421 |
TRG_DiLeu_BaEn_2 | 105 | 111 | PF01217 | 0.474 |
TRG_ENDOCYTIC_2 | 153 | 156 | PF00928 | 0.402 |
TRG_ENDOCYTIC_2 | 66 | 69 | PF00928 | 0.455 |
TRG_ER_diArg_1 | 37 | 39 | PF00400 | 0.516 |
TRG_ER_diArg_1 | 76 | 78 | PF00400 | 0.502 |
TRG_NLS_MonoExtN_4 | 78 | 85 | PF00514 | 0.552 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0S4IY51 | Bodo saltans | 66% | 100% |
A0A1X0P9W6 | Trypanosomatidae | 69% | 100% |
A0A1X0P9X9 | Trypanosomatidae | 71% | 100% |
A0A3Q8IFE1 | Leishmania donovani | 94% | 100% |
A0A3Q8INI0 | Leishmania donovani | 95% | 100% |
A0A3R7KIF6 | Trypanosoma rangeli | 69% | 100% |
A0A422NEU2 | Trypanosoma rangeli | 73% | 100% |
A4HAZ5 | Leishmania braziliensis | 99% | 100% |
A4I4Y2 | Leishmania infantum | 94% | 100% |
A4IA55 | Leishmania infantum | 96% | 100% |
E9AEE8 | Leishmania major | 94% | 100% |
E9ALD8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 94% | 100% |
E9B569 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 96% | 100% |
Q4Q2R6 | Leishmania major | 96% | 100% |